These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9221930)

  • 1. Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat.
    Salin P; Dziewczapolski G; Gershanik OS; Nieoullon A; Raisman-Vozari R
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):311-21. PubMed ID: 9221930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat.
    Zeng BY; Jolkkonen J; Jenner P; Marsden CD
    Neuroscience; 1995 May; 66(1):19-28. PubMed ID: 7637869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum.
    Salin P; Kachidian P
    Brain Res Mol Brain Res; 1998 Jun; 57(2):257-65. PubMed ID: 9675424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
    Zeng BY; Jenner P; Marsden CD
    Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.
    Pirker W; Tedroff J; Pontén H; Gunne L; Andrén PE; Hurd YL
    Exp Neurol; 2001 May; 169(1):122-34. PubMed ID: 11312565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata.
    Wang H; Katz J; Dagostino P; Soghomonian JJ
    Neuroscience; 2007 Mar; 145(2):727-37. PubMed ID: 17218060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.
    Périer C; Marin C; Bonastre M; Tolosa E; Hirsch EC
    Eur J Neurosci; 2002 Dec; 16(11):2236-40. PubMed ID: 12473092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
    Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
    Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment.
    Medhurst AD; Zeng BY; Charles KJ; Gray J; Reavill C; Hunter AJ; Shale JA; Jenner P
    Neuroscience; 2001; 105(2):353-64. PubMed ID: 11672603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD; De Ceballos ML; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1992 Aug; 219(2):183-92. PubMed ID: 1385171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P; Chalon S; Brotchie JM; Crossman AR
    Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in the dopamine-denervated rat striatum.
    Campbell K; Björklund A
    Eur J Neurosci; 1994 Aug; 6(8):1371-83. PubMed ID: 7981878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.
    Westin JE; Andersson M; Lundblad M; Cenci MA
    Eur J Neurosci; 2001 Oct; 14(7):1171-6. PubMed ID: 11683909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
    Mavridis M; Rogard M; Besson MJ
    Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T
    Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
    Ko WK; Martin-Negrier ML; Bezard E; Crossman AR; Ravenscroft P
    Neurobiol Dis; 2014 Oct; 70():138-48. PubMed ID: 24969021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.